EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Alpha-Mangostin in Acute Kidney Injury: Molecular Mechanisms, Regulated Cell Death, and Translational Opportunities

Atthaphong Phongphithakchai iD, Nawanwat C Pattaranggoon iD, Kraiyasak Wongna, Ratana Netphakdee iD, Aman Tedasen, Chutima Jansakun iD, Wiyada Kwanhian Klangbud iD, Jongkonnee Thanasai iD, Fumitaka Kawakami iD, Moragot Chatatikun iD

Antioxidants · 23.07.2026 · 15 (8) · 915

DOI: 10.3390/antiox15080915 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 23.07.2026. Verfasst von Atthaphong Phongphithakchai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute kidney injury (AKI) is a major global health challenge associated with substantial morbidity, mortality, and progression to chronic kidney disease. Increasing evidence indicates that oxidative stress, mitochondrial dysfunction, inflammatory signaling, regulated cell death, and maladaptive tissue repair play central roles in AKI pathogenesis, yet effective disease-modifying pharmacological therapies remain unavailable. This narrative review critically evaluated current evidence regarding the pharmacological characteristics, molecular mechanisms, and translational potential of alpha-mangostin (AM), the principal prenylated xanthone isolated from the pericarp of Garcinia mangostana L., through a comprehensive synthesis of experimental and mechanistic studies. Available preclinical evidence consistently demonstrates that AM improves renal function and attenuates histopathological injury, particularly in cisplatin-induced nephrotoxicity and glycerol-induced rhabdomyolysis models. These renoprotective effects are primarily associated with suppression of oxidative stress, activation of the Nrf2/HO-1 antioxidant pathway, inhibition of NF-κB-mediated inflammatory signaling, preservation of mitochondrial function, and attenuation of apoptosis. Several emerging pathways may also contribute to AM-mediated renoprotective effects; however, current evidence remains indirect, and their roles require validation in kidney-specific models. Clinical translation remains limited by poor oral bioavailability, insufficient pharmacokinetic data, lack of standardized formulations, and the absence of human clinical trials. Overall, current evidence suggests that AM has preliminary renoprotective potential in experimental AKI models. However, the limited number of available studies, predominance of cisplatin-induced nephrotoxicity models, insufficient pharmacokinetic and safety data, and absence of human clinical studies preclude conclusions regarding its clinical efficacy or translational readiness. Further validation in diverse and clinically relevant AKI models is required before clinical investigation can be considered.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injuryalpha-mangostinapoptosisinflammationmitochondriaoxidative stresstranslational medicine

Autor:innen und Institutionen

  • Nephrology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  • School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80160, Thailand.
  • Research Excellence Center for Innovation and Health Products, Walailak University, Tha Sala, Nakhon Si Thammarat 80161, Thailand.
  • Medical Technology Program, Faculty of Science, Nakhon Phanom University, Nakhon Phanom 48000, Thailand.
  • Faculty of Medicine, Mahasarakham University, Mahasarakham 44000, Thailand.
  • Department of Regulation Biochemistry, Graduate School of Medical Sciences, Kitasato University, Sagamihara 252-0373, Japan.

ORCID-Profile: Atthaphong Phongphithakchai, Nawanwat C Pattaranggoon, Ratana Netphakdee, Chutima Jansakun, Wiyada Kwanhian Klangbud, Jongkonnee Thanasai, Fumitaka Kawakami, Moragot Chatatikun

Zitieren

APA

Phongphithakchai, A., Pattaranggoon, N. C., Wongna, K., Netphakdee, R., Tedasen, A., Jansakun, C., Klangbud, W. K., Thanasai, J., Kawakami, F., & Chatatikun, M. (2026). Alpha-Mangostin in Acute Kidney Injury: Molecular Mechanisms, Regulated Cell Death, and Translational Opportunities. Antioxidants, 15(8), 915. https://doi.org/10.3390/antiox15080915

Vancouver

Phongphithakchai A, Pattaranggoon NC, Wongna K, Netphakdee R, Tedasen A, Jansakun C, et al. Alpha-Mangostin in Acute Kidney Injury: Molecular Mechanisms, Regulated Cell Death, and Translational Opportunities. Antioxidants. 2026;15(8):915. doi:10.3390/antiox15080915

BibTeX
@article{Phongphithakchai2026,
  author = {Phongphithakchai, Atthaphong and Pattaranggoon, Nawanwat C and Wongna, Kraiyasak and Netphakdee, Ratana and Tedasen, Aman and Jansakun, Chutima and Klangbud, Wiyada Kwanhian and Thanasai, Jongkonnee and Kawakami, Fumitaka and Chatatikun, Moragot},
  title = {Alpha-Mangostin in Acute Kidney Injury: Molecular Mechanisms, Regulated Cell Death, and Translational Opportunities},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {915},
  doi = {10.3390/antiox15080915}
}
Kostenlos starten →